Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomised, Placebo-controlled, Parallel Group, International, Multi-centre Phase 2 Trial Investigating the Safety and Efficacy of CRD007 in Adult Subjects With Asthma

NCT02615080 is registered in ClinicalTrials.gov with RSPR Pharma AB as lead sponsor.

NCT NCT02615080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomised, Placebo-controlled, Parallel Group, International, Multi-centre Phase 2 Trial Investigating the Safety and Efficacy of CRD007 in Adult Subjects With Asthma
Lead sponsor
RSPR Pharma AB
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2015
Completion date
February 24, 2017
Enrollment
168 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

asthma